Poland· PL-100278590

Levetiracetam Aurovitas

A levetiracetam product containing levetiracetamum, registered in Poland by Aurovitas Pharma Polska Sp. z o.o.. The same ATC class is registered in 19 of our 19 countries.

ATC N03AX14

Checked against URPL (Poland) on September 27, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about levetiracetamumAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Levetiracetam is registered in 19 of 19 countries.

Countries holding a registration under ATC N03AX14 (levetiracetam), each read from that country’s own register.

This record: Poland, from URPL (Poland)
11 of them publish a price we can compare per daily dose

Search levetiracetam products by name

Levetiracetam · ATC N03AX14

19 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Italyprice
Japan
Netherlands
Norwayprice
Polandprice
Spainprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of levetiracetam costs, country by country.

Normalised to the WHO defined daily dose (1.5 g), the median price runs from $1.19 in France to $3.10 in Spain — a ×2.6 gap.

4 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Levetiracetam · price per daily dose (1.5 g)

USD · FX 28 Sept 2026

ES Spain$3.10
CH Switzerland$2.54
IT Italy$2.14
FR France$1.19

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)

Active substance: Levetiracetamum
Manufacturer: Aurovitas Pharma Polska Sp. z o.o.
Country: Poland (PL)
ATC code: N03AX14
ATC class: Levetiracetam
Defined daily dose: 1.5 g, O
Reimbursed: Not published by this register
Source register: URPL (Poland)
Last checked: September 27, 2026

Packs & prices · 11

1 priced

gtin
05909990971305
50 szt.
PLN 51.25
gtin
05909990971329
gtin
05909990971282
gtin
05909990971299
gtin
05909990971336
gtin
05909990971343
gtin
05909990971350
gtin
05909990971367
gtin
05909990971374
gtin
05909990971381
gtin
05909990971398

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

258 interactions on record for levetiracetam.

Graded by severity as the source publishes them — 50 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check levetiracetam against other medicines How interaction checks work

Levetiracetam · interactions on record

258 records

50 moderate
3 minor
164 info

Most severe, free to view

MetoclopramideA03FA01moderate
DiphenhydraminA04AB05moderate
DronabinolA04AD10moderate
NabiloneA04AD11moderate

41 more interactions with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Levetiracetam in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All levetiracetam products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

Austria · Levebon, Levetiracetam +pharma
Belgium · Larofec, Levetiracetam A.Forall
Bulgaria · Levebon, Леветиракон Pharmacons
Cyprus · Levetiracetam Noridem, Lyberen
Czechia · Dretacen, Epiletam
Germany · Levetiracetam 1 A Pharma, Levetiracetam Aaa
Denmark · Kevesy, Levetiracetam ”1a Farma”
Estonia · Levetiracetam Zentiva, Normeg
Spain · Laurak, Levetiracetam Almus
Finland · Larofec, Levetiracetam 1a Farma
France · Levetiracetam Accord, Levetiracetam Aguettant
United Kingdom (Northern Ireland) · Desitrend, Genlev
Greece · Ession, Kepricet
Croatia · Levetiracetam Kalceks, Lyvam
Hungary · Epiletam, Levetiracetam Kabi
Ireland · Larofec, Levetiracetam Brillpharma
Iceland · Keppra, Levetiracetam Accord
Italy · Epitiram, Grifoxina
Liechtenstein · Keppra, Levetiracetam Accord
Lithuania · Dretacen, Levetiracetam Kalceks
Luxembourg · Larofec, Levetiracetam Micro Labs
Latvia · Levetiracetam Kalceks
Malta · Levetiracetam Accord, Levetiracetam Aurobindo
Netherlands · Dretacen, Larofec
Norway · Keppra, Larofec
Portugal · Cinaz, Laurak
Romania · Levetiracetam Accord, Levetiracetam Arena
Sweden · Levebon, Levetiracetam
Slovenia · Levetiracetam Kalceks
Slovakia · Epiletam, Levetiracetam

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/dbe10def-02c3-436f-8aca-0a6d7556a1ca
GET /v1/drugs/dbe10def-02c3-436f-8aca-0a6d7556a1ca?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki powlekane",
  "source": "urpl",
  "strength": "1000 mg",
  "packaging": "05909990971282 ¦ Rp ¦ 76140\n20 tabl.\n05909990971299 ¦ Rp ¦ 76141\n30 tabl. w blistrze\n05909990971305 ¦ Rp ¦ 76142\n50 tabl.\n05909990971329 ¦ Rp ¦ 76143\n60 tabl.\n05909990971336 ¦ Rp ¦ 76144\n100 tabl. w blistrze\n05909990971343 ¦ Rp ¦ 76145\n200 tabl. w blistrze\n05909990971350 ¦ Rp ¦ 76146\n500 tabl. w blistrze\n05909990971367 ¦ Rp ¦ 76147\n1 poj. 30 tabl.\n05909990971374 ¦ Rp ¦ 76148\n1 poj. 100 tabl.\n05909990971381 ¦ Rp ¦ 76149\n1 poj. 200 tabl.\n05909990971398 ¦ Rp ¦ 76150\n1 poj. 500 tabl.",
  "substance": "Levetiracetamum 1000 mg",
  "common_name": "Levetiracetamum",
  "pl_product_id": "100278590",
  "pozwolenie_nr": "20073",
  "auth_procedure": "DCP",
  "authorisation_validity": "Bezterminowe"
}

API reference MCP server Plans

See everything about levetiracetam.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console